{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:32:47Z","timestamp":1767889967644,"version":"3.49.0"},"reference-count":20,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine (Lond.)"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.2217\/nnm-2019-0402","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T10:47:30Z","timestamp":1581677250000},"page":"543-545","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Immuno-Nanocarriers for Brain Delivery: Limitations From\n            <i>In Vitro<\/i>\n            to Preclinical and Clinical Studies"],"prefix":"10.1080","volume":"15","author":[{"given":"Joana A","family":"Loureiro","sequence":"first","affiliation":[{"name":"LEPABE \u2013 Laboratory for Process Engineering, Environment, Biotechnology &amp; Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465, Porto, Portugal"}]},{"given":"Maria Jo\u00e3o","family":"Ramalho","sequence":"additional","affiliation":[{"name":"LEPABE \u2013 Laboratory for Process Engineering, Environment, Biotechnology &amp; Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465, Porto, Portugal"}]},{"given":"Maria do","family":"Carmo Pereira","sequence":"additional","affiliation":[{"name":"LEPABE \u2013 Laboratory for Process Engineering, Environment, Biotechnology &amp; Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465, Porto, Portugal"}]}],"member":"301","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01261"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120490"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040269"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.12.015"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.3762\/bjnano.9.98"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-018-2457-x"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.14.27"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2010.05.003"},{"issue":"3","key":"e_1_3_2_10_1","first-page":"1048","article-title":"Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood\u2013brain barrier in mouse","volume":"292","author":"Lee HJ","year":"2000","unstructured":"Lee HJ , EngelhardtB, LesleyJ, BickelU, PardridgeWM. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood\u2013brain barrier in mouse. J. Pharmacol. Exp. Ther.292(3), 1048\u20131052 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.04.035"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018829920158"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.11.7011"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22030355"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2016.04.041"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.4155\/fso.15.71"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2015.06.067"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.04.062"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22020277"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.135"},{"key":"e_1_3_2_21_1","unstructured":"ClinicalTrials.gov NCT02340156 . Phase II study of combined temozolomide and SGT-53 for treatment of recurrent glioblastoma (2019). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02340156"}],"container-title":["Nanomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nnm-2019-0402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:50:39Z","timestamp":1716493839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nnm-2019-0402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.2217\/nnm-2019-0402"],"URL":"https:\/\/doi.org\/10.2217\/nnm-2019-0402","relation":{},"ISSN":["1743-5889","1748-6963"],"issn-type":[{"value":"1743-5889","type":"print"},{"value":"1748-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}